| Literature DB >> 17029645 |
Emma Brunberg1, Leif Andersson, Gus Cothran, Kaj Sandberg, Sofia Mikko, Gabriella Lindgren.
Abstract
BACKGROUND: The Silver coat color, also called Silver dapple, in the horse is characterized by dilution of the black pigment in the hair. This phenotype shows an autosomal dominant inheritance. The effect of the mutation is most visible in the long hairs of the mane and tail, which are diluted to a mixture of white and gray hairs. Herein we describe the identification of the responsible gene and a missense mutation associated with the Silver phenotype.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17029645 PMCID: PMC1617113 DOI: 10.1186/1471-2156-7-46
Source DB: PubMed Journal: BMC Genet ISSN: 1471-2156 Impact factor: 2.797
Figure 1Phenotypic description of Silver colored horses. A. A Black Silver Icelandic horse. A genetically black horse that exhibits the typical silver phenotype with a dark body with dapples and a shiny white mane and tail. Photo: Tim Kvick. B. Two Black Silver Rocky Mountain Horses. Photo: Bob Langrish. C. A Brown Silver Morgan horse. A genetically brown horse that shows the silver phenotype with the mane and tail diluted from black to white and the lower legs diluted from black to dark greyish. Photo: Laura Behning. D. The legs of a Brown Silver horse. The lower legs are diluted from black to greyish. Photo: Laura Behning.
Figure 2Phenotypic description of Silver colored foals. A. A Silver colored Icelandic horse foal. Silver foals are generally very pale on the body with white mane and tail. Photo: Elsa Storgärds. B. A striped hoof of a Silver colored Icelandic horse foal. Photo: Tim Kvick. C. White eyelashes of a Silver colored Rocky Mountain Horse colt. Photo: Unknown.
Figure 3A chestnut Morgan horse that carry the . This particular individual (Amanda's Suzie Q) indicate that the Silver mutation in horses has little or no effect on pheomelanin (as mane does not seem to be diluted). Photo: Anthony Domire JR.
Figure 4A schematic picture of the PMEL17 protein with domains and known mutations. The transmembrane (TM) protein PMEL17 has previously been shown to regulate hypopigmented phenotypes in mouse, chicken, dog, and zebrafish. The location of known mutations associated with hypopigmentation in these species are indicated. R740C in chicken (Dun) is at the same location as the R618C in the horse (Silver).
Figure 5Amino acid alignment of the end of the transmembrane region and beginning of the cytoplasmic region of the PMEL17. Amino acid alignment of the end of the transmembrane region and beginning of the cytoplasmic region of the PMEL17. The site of the silver horse mutation is highlighted. Sequence identities are indicated by dashes and insertion/deletion differences are indicated by dots.
Numbers of individuals from different breeds tested for PMEL17 mutations associated with the Silver phenotype in horses.
| Silver | Non Silver | Silver | Non Silver | |||
| TT | CT | CC | TT | AT | AA | |
| Icelandic horse | 1 | 49 | 40 | 1 | 30 | 22 |
| American miniature | 1 | 5 | 8 | 1 | 4 | 6 |
| Rocky mountain horse | 2 | 3 | 3 | 2 | 3 | 4 |
| Morgan horse | 4 | 3 | 3 | 2 | ||
| Swedish warmblood | 2 | 3 | 1 | 3 | ||
| Ardenne | 1 | 3 | 1 | 3 | ||
| Connemara pony | 4 | 2 | ||||
| Shetland pony | 4 | 4 | ||||
| Haflinger | 4 | 3 | ||||
| Thoroughbred | 3 | 3 | ||||
| Welsh pony | 3 | 3 | ||||
| North Swedish horse | 3 | 2 | ||||
| Norwegian fjordhorse | 2 | 2 | ||||
| New forest pony | 2 | 2 | ||||
Primer sequences for the sequencing of horse PMEL17
| 5'UTR-Intron1 | GGATCCCTTGTCAGTTTTGC | AGGAGAGGAAAAACCAGAGC |
| Exon 1-Exon 2 (LR) | GATGGATCCAGTGTCAGAGATG | ACTCTGGATACAGCTGCCTGTT |
| Intron 1-Exon 2 | CGTGGGATGACGTTATCTTCT | AGTCAGGCCCCTGAATTTCT |
| Exon 2–3 | GTCTCAAGGCAGCTCAGGAA | CATTGATGATGGTGTTGTTGG |
| Exon 3–4 (LR) | CTACACTGGTTGGGGCAAAT | TCTGAGACAGAGGGCCAGAT |
| Exon 3-Intron 3 | GGTGGCCCTGAAGATCAGTA | AGGGAATTGGAGCCCTTAGA |
| Intron 3-Exon 4 | CTCTCTGGGAGCCGTGTTAG | CCCAGGTCTTCCAGACGTAA |
| Exon 4-Intron 4 | TCCCCAGGAACCTGATGATA | CTTCAGAGGTGGGACCAGAG |
| Exon 4–5 | TCCCCAGGAACCTGATGATA | GCGGTGGTAGACAGTCACTT |
| Exon 5–6 | AGTGTCGGGGCTGAGCAT | CAGGCCACAGCTTGTCTTTT |
| Exon 5–6(2) | TGCCCCTCGCTCACTCCCGCTCAGCCT | CATGAATGGGCTGGCATCTGGA |
| Exon 6–7 | GGTAACGGTACAGAGTTGGTGGAA | GGACGATGTCCAGAGTGAGGGA |
| Exon 6–7(2) | AGGTGCCAACTGCAGAGC | GGACGATGTCCAGAGTGAGG |
| Exon 7-Intron 8 | ATGGCACAGCCACCTTATTC | GAAAGGTGTCAGTTTAGGTCAGG |
| Exon 7–10 | CCAGAGCCCCCTGCTGGATGG | TATATCAGAGATGCAAGCACCATA |
| Exon 9-Intron 10 | AATGTGTCTTTGGCTGATGC | TCTGCCCCTCTTACAGGTGA |
| Intron 10-Exon 11 | GCAGGGAAGCTTGTAGAGTGA | CTCTCACCAAAGGGGGAAG |
| Exon 10–11 | AGAGGCAGGCCTTGGGCAG | TGCTCTCACCAAAGGGGGAAG |
| Exon 11–3'UTR | CAGGCGCAGACTTATGAAGC | AGGGAAGWCTGSRGRAAABA |
| Pyroseq. PCR primers, Ex 11 | Biotin-TCCATTGCTTACCAGTTTCCTT | CTCACCAAAGGGGGAAGAG |
| Pyroseq. Seq primer, Ex 11 | - | GCCCTGCTTCATAAGTCTG |
| Pyroseq. PCR primers, Int.9 | CATGCCTGGTAGGTACTTGGA | Biotin-CCTCTTGACCTGTGAGCAGA |
| Pyroseq. Seq primer, Int 9. | GGGGAGTGGGCAGAGGCT | - |
| RACE primer | - | CCGGAGGGCAAAGGTCAGAGGTTG |